Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in VERA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Avoro Capital Advisors LLC | 5.9M | $236.9M | 0.0% | 8.212% | 2.42% |
| 2 | BlackRock, Inc. | 5.1M | $204.7M | +5.4% | 7.095% | 0.00% |
| 3 | Deep Track Capital, LP | 4.1M | $165.2M | +45.6% | 5.726% | 3.41% |
| 4 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.7M | $149.7M | -8.3% | 5.190% | 1.77% |
| 5 | Kynam Capital Management, LP | 3.4M | $136.7M | -1.0% | 4.739% | 8.54% |
| 6 | STATE STREET CORP | 3.4M | $135.3M | +25.7% | 4.690% | 0.00% |
| 7 | Sofinnova Investments, Inc. | 2.8M | $112.4M | 0.0% | 3.896% | 5.89% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $108.0M | β | 3.742% | 0.00% |
| 9 | FMR LLC | 2.7M | $107.7M | -7.3% | 3.732% | 0.01% |
| 10 | Eversept Partners, LP | 2.2M | $87.4M | -29.3% | 3.030% | 5.70% |
| 11 | Bellevue Group AG | 1.7M | $68.8M | +0.7% | 2.386% | 1.64% |
| 12 | ALLIANCEBERNSTEIN L.P. | 1.3M | $66.6M | +7.8% | 1.833% | 0.02% |
| 13 | Integral Health Asset Management, LLC | 1.6M | $64.4M | -11.1% | 2.231% | 3.98% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $63.2M | +8.7% | 2.189% | 0.00% |
| 15 | Vestal Point Capital, LP | 1.4M | $55.0M | +148.8% | 1.908% | 1.54% |
| 16 | Point72 Asset Management, L.P. | 1.2M | $49.4M | -29.3% | 1.713% | 0.07% |
| 17 | GOLDMAN SACHS GROUP INC | 1.1M | $45.6M | +1.2% | 1.581% | 0.01% |
| 18 | Pictet Asset Management Holding SA | 1.1M | $42.3M | -24.5% | 1.466% | 0.05% |
| 19 | Woodline Partners LP | 1.0M | $40.3M | +0.1% | 1.396% | 0.15% |
| 20 | AMERICAN CENTURY COMPANIES INC | 728K | $29.3M | -0.6% | 1.016% | 0.02% |
| 21 | BANK OF AMERICA CORP /DE/ | 590K | $23.7M | -15.1% | 0.822% | 0.00% |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLC | 553K | $22.2M | β | 0.771% | 0.00% |
| 23 | FRONTIER CAPITAL MANAGEMENT CO LLC | 551K | $22.2M | +48.6% | 0.769% | 0.23% |
| 24 | CITADEL ADVISORS LLC | 542K | $21.8M | -36.3% | 0.756% | 0.01% |
| 25 | Qube Research & Technologies Ltd | 542K | $21.8M | +43.3% | 0.756% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in VERA β a direct measure of their conviction.
Filings activity in VERA during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new VERA position in Q1 2026
Institutions that fully closed their VERA position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 221 | +5.7% | 111.33% | 29.29 pp | $2.74B | 21% |
| Q4 2025 | 209 | +23% | 140.62% | +68.31 pp | $3.45B | +94% |
| Q3 2025 | 170 | +1.2% | 72.31% | +16.02 pp | $1.78B | +28% |
| Q2 2025 | 168 | 4.0% | 56.29% | +0.88 pp | $1.38B | +1.6% |
| Q1 2025 | 175 | 0.6% | 55.41% | 40.13 pp | $1.36B | 42% |
| Q4 2024 | 176 | +1.7% | 95.54% | +9.23 pp | $2.35B | +11% |
| Q3 2024 | 173 | +1.8% | 86.31% | +14.33 pp | $2.12B | +20% |
| Q2 2024 | 170 | β | 71.98% | β | $1.77B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying VERA stock.
Based on Q1 2026 13F filings, institutional ownership of Vera Therapeutics, Inc. stands at 111.3%, held across 221 reporting institutions.
Avoro Capital Advisors LLC is the largest reported institutional holder of VERA, with approximately 5,888,888 shares worth $0.24B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of VERA, including Point72 Asset Management, L.P., CITADEL ADVISORS LLC.
Our composite Smart Money Score for VERA is 47 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
46 institutions opened new positions in VERA during Q1 2026, while 34 fully exited. 46 added to existing positions and 127 trimmed.
VERA institutional ownership fell by 29.29 percentage points quarter-over-quarter, with a net change of +12 holders.
The top 10 institutions account for 52.8% of all reported 13F value in VERA, and the top 25 account for 76.1%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Vera Therapeutics, Inc. (VERA) Institutional Ownership